4//SEC Filing
Feller Faye 4
Accession 0001062993-23-018391
CIK 0000886744other
Filed
Sep 20, 8:00 PM ET
Accepted
Sep 21, 8:31 PM ET
Size
7.7 KB
Accession
0001062993-23-018391
Insider Transaction Report
Form 4
GERON CORPGERN
Feller Faye
EVP, Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2023-08-15+20,000→ 20,000 totalExercise: $1.06From: 2023-08-15Exp: 2032-02-15→ Common Stock (20,000 underlying) - Award
Employee Stock Option (right to buy)
2023-08-15+180,000→ 180,000 totalExercise: $1.93From: 2023-08-15Exp: 2032-07-07→ Common Stock (180,000 underlying)
Footnotes (2)
- [F1]Performance-based stock option granted on February 16, 2022 and vested in full on August 15, 2023 upon acceptance of the NDA by the US FDA for imetelstat in lower risk MDS.
- [F2]Performance-based stock option granted on July 8, 2022 and vested in full on August 15, 2023 upon acceptance of the NDA by the US FDA for imetelstat in lower risk MDS.
Issuer
GERON CORP
CIK 0000886744
Entity typeother
Related Parties
1- filerCIK 0001937361
Filing Metadata
- Form type
- 4
- Filed
- Sep 20, 8:00 PM ET
- Accepted
- Sep 21, 8:31 PM ET
- Size
- 7.7 KB